Theseus Pharmaceuticals, Inc. Position Boosted by Denali Advisors LLC
THRXDelisted Stock | USD 3.71 0.14 3.92% |
Slightly above 55% of Theseus Pharmaceuticals' investors are presently thinking to get in. The analysis of current outlook of investing in Theseus Pharmaceuticals suggests that some traders are interested regarding Theseus Pharmaceuticals' prospects. Theseus Pharmaceuticals' investing sentiment can be driven by a variety of factors including economic data, Theseus Pharmaceuticals' earnings reports, geopolitical events, and overall market trends.
Theseus |
Denali Advisors LLC increased its stake in shares of Theseus Pharmaceuticals, Inc. by 675.2 percent in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 127,900 shares of the companys stock after purchasing an additional 111,400 shares during the quarter. Denali
Read at thelincolnianonline.com
Theseus Pharmaceuticals Fundamental Analysis
We analyze Theseus Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Theseus Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Theseus Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Theseus Pharmaceuticals is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Theseus Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Theseus Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Theseus Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Theseus Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Theseus Pharmaceuticals Related Equities
ERAS | Erasca | 12.94 | ||||
DSGN | Design Therapeutics | 4.67 | ||||
PMVP | Pmv Pharmaceuticals | 4.32 | ||||
RCUS | Arcus Biosciences | 3.24 | ||||
HOOK | Hookipa Pharma | 2.38 | ||||
BPMC | Blueprint Medicines | 1.29 | ||||
MRSN | Mersana Therapeutics | 0.88 | ||||
IMRX | Immuneering Corp | 0.48 | ||||
ELVN | Enliven Therapeutics | 0.21 | ||||
RLAY | Relay Therapeutics | 0.64 | ||||
DAWN | Day One | 0.65 | ||||
GLUE | Monte Rosa | 1.35 | ||||
TERN | Terns Pharmaceuticals | 1.44 | ||||
CGEM | Cullinan Oncology | 2.08 | ||||
IPSC | Century Therapeutics | 2.33 | ||||
XFOR | X4 Pharmaceuticals | 5.13 |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Theseus Stock
If you are still planning to invest in Theseus Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Theseus Pharmaceuticals' history and understand the potential risks before investing.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |